Healthcare & Well-beingSri Lanka's National Cancer Institute Benefits from His Holiness' Patronage

Sri Lanka’s National Cancer Institute Benefits from His Holiness’ Patronage

In 2019, the Head of the Dawoodi Bohra Community, His Holiness Dr Syedna Mufaddal Saifuddin contributed towards infrastructure and capacity expansion of the National Cancer Institute’s (NCI) Bone Marrow Transplant Unit (BMTU).

The National Cancer Institute (NCI) of Sri Lanka has been recognised for its outstanding accomplishments in autologous transplant services at the Asia-Pacific BM Transplant Annual Congress in Taiwan (2018) and the American Society of Haematology in the USA, as one of the best services in the developing world.

The NCI and National Blood Transfusion Service (NBTS) have taken the next step to provide a potentially curative allogeneic transplant service (using donor blood stem cells) to patients who suffer from leukaemia, thalassemia and other life-threatening blood conditions that are not treated by autologous stem cell transplant (SCT).

The donation by His Holiness has aided in substantially increasing the number of beds in the Stem Cell Transplant unit at the NCI, giving even more patients the opportunity to benefit from the lifesaving bone marrow treatment.

The extended unit was inaugurated on Friday, 29th January 2021. The management appreciated the support and generosity of His Holiness and the Dawoodi Bohras of Sri Lanka.

His Holiness Dr Syedna Mufaddal Saifuddin has always devoted resources to improving healthcare and providing the latest in medical care facilities. In addition to his contribution towards the NCI’s stem cell transplant unit, Syedna has also contributed towards enhancing the facilities and improving welfare and preventative care for patients impacted by chronic kidney disease in Sri Lanka.